Golimumab for the treatment of psoriatic arthritis

Review proposal consultation

Stakeholder matrix (PDF 40 KB)

Review proposal paper (PDF 290 KB)

Psoriatic arthritis - golimumab: review proposal - June 2013 information

TA220 Psoriatic arthritis - golimumab: Appendix A provisional matrix of stakeholders (PDF 39 KB)

TA220 Psoriatic arthritis - golimumab: Appendix B - proposal paper presented to the Institute's Guidance Executive (PDF 444 KB)

Psoriatic arthritis - golimumab: EIA form (PDF 77 KB)

Psoriatic arthritis - golimumab: final appraisal determination  information

Psoriatic arthritis - golimumab: final appraisal determination document (PDF 232 KB)

Psoriatic arthritis - golimumab: response to consultee, commentator and public comments on the ACD and comments from website consultation (PDF 414 KB)

Psoriatic arthritis - golimumab: consultee and commentator comments on the ACD

Psoriatic arthritis - golimumab: Merck Sharp & Dohme (formerly Schering-Plough) (PDF 1.17 MB)

Psoriatic arthritis - golimumab: Psoriasis and Psoriatic Arthritis Alliance (PDF 134 KB)

Psoriatic arthritis - golimumab: Psoriasis Association (PDF 167 KB)

Psoriatic arthritis - golimumab: British Association of Dermatologists (endorsed by Royal College of Physicians) (PDF 5.4 KB)

Psoriatic arthritis - golimumab: British Health Professionals in Rheumatology (PDF 189 KB)

Psoriatic arthritis - golimumab: British Society for Rheumatology (endorsed by Royal College of Physicians) (PDF 158 KB)

Psoriatic arthritis - golimumab: Royal College of Nursing (PDF 59 KB)

Psoriatic arthritis - golimumab: Royal College of Pathologists (PDF 37 KB)

Psoriatic arthritis - golimumab: Abbott (PDF 129 KB)

Psoriatic arthritis - golimumab: expert comments on the ACD

Psoriatic arthritis - golimumab: Sue Ashwell, NHS commissioning expert nominated by NHS Cambridgeshire on behalf of NHS Havering (PDF 24 KB)

Psoriatic arthritis - golimumab: web comments on the ACD (PDF 49 KB)

Psoriatic arthritis - golimumab: Manufacturer response to request for additional information from Merck Sharp & Dohme (formerly Schering-Plough) (PDF 371 KB)

Psoriatic arthritis - golimumab: appraisal consultation

Psoriatic arthritis - golimumab: appraisal consultation document information

Psoriatic arthritis - golimumab: evaluation report

Psoriatic arthritis - golimumab: pre-meeting briefing (PDF 451 KB)

Psoriatic arthritis - golimumab: Evidence Review Group report (PDF 748 KB)

Psoriatic arthritis - golimumab: manufacturer submission (PDF 2.84 MB)

Psoriatic arthritis - golimumab: NICE clarification letter (PDF 98 KB)

Psoriatic arthritis - golimumab: manufacturer response to clarification letter (PDF 863 KB)

Psoriatic arthritis - golimumab: non-manufacturer submissions

Psoriatic arthritis - golimumab: non-manufacturer submissions - Psoriasis and Psoriatic Arthritis Alliance (PDF 82 KB)

Psoriatic arthritis - golimumab: non-manufacturer submissions - British Association of Dermatologists (endorsed by Royal College of Physicians) (PDF 87 KB)

Psoriatic arthritis - golimumab: non-manufacturer submissions - British Health Professionals in Rheumatology (PDF 80 KB)

Psoriatic arthritis - golimumab: non-manufacturer submissions - British Society for Rheumatology (PDF 56 KB)

Psoriatic arthritis - golimumab: non-manufacturer submissions - Primary Care Rheumatology Society (PDF 131 KB)

Psoriatic arthritis - golimumab: non-manufacturer submissions - Royal College of Pathologists (PDF 57 KB)

Psoriatic arthritis - golimumab: non-manufacturer submissions - NHS Cambridgeshire on behalf of NHS Havering (PDF 128 KB)

Psoriatic arthritis - golimumab: expert written personal statements

Psoriatic arthritis - golimumab: expert written personal statements - Anstey (PDF 19 KB)

Psoriatic arthritis - golimumab: expert written personal statements - Ashwell (PDF 7.8 KB)

Psoriatic arthritis - golimumab: expert written personal statements - Helliwell (PDF 78 KB)

Psoriatic arthritis - golimumab: expert written personal statements - James (PDF 161 KB)

Psoriatic arthritis - golimumab: expert written personal statements - Korendowych (PDF 14 KB)

Psoriatic arthritis - golimumab: final matrix (PDF 33 KB)

Psoriatic arthritis - golimumab: final scope (PDF 42 KB)